GSK Invests €250 Million to Allow Freeze-Drying of Vaccines
GSK Plc will invest more than €250 million ($272 million) in a Belgian site for vaccines as the country builds on its position as a global health and biotech hub. #press

GSK Invests €250 Million to Allow Freeze-Drying of Vaccines
GSK Plc will invest more than €250 million ($272 million) in a Belgian site for vaccines as the country builds on its position as a global health and biotech hub. #press

No replies yet.